These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34779230)

  • 1. Circulating Extracellular Vesicles Contain Liver-Derived RNA Species as Indicators of Severe Cholestasis-Induced Early Liver Fibrosis in Mice.
    Fagoonee S; Arigoni M; Manco M; Olivero M; Bizzaro F; Magagnotti C; Andolfo A; Miniscalco B; Forni M; Todeschi S; Tolosano E; Bocchietto E; Calogero R; Altruda F
    Antioxid Redox Signal; 2022 Mar; 36(7-9):480-504. PubMed ID: 34779230
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
    Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
    J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
    Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
    Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis.
    Povero D; Pinatel EM; Leszczynska A; Goyal NP; Nishio T; Kim J; Kneiber D; de Araujo Horcel L; Eguchi A; Ordonez PM; Kisseleva T; Feldstein AE
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway.
    Abdel-Rahman N; Sharawy MH; Megahed N; El-Awady MS
    Toxicol Appl Pharmacol; 2019 Oct; 380():114697. PubMed ID: 31394158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries.
    Li SC; Wang FS; Yang YL; Tiao MM; Chuang JH; Huang YH
    Int J Mol Sci; 2016 Mar; 17(3):324. PubMed ID: 26938532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-200c-3p targets SESN1 and represses the IL-6/AKT loop to prevent cholangiocyte activation and cholestatic liver fibrosis.
    Song Y; Tran M; Wang L; Shin DJ; Wu J
    Lab Invest; 2022 May; 102(5):485-493. PubMed ID: 34880414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
    Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of necroptosis in human and experimental cholestasis.
    Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
    Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis.
    Chen L; Zhou T; Wu N; O'Brien A; Venter J; Ceci L; Kyritsi K; Onori P; Gaudio E; Sybenga A; Xie L; Wu C; Fabris L; Invernizzi P; Zawieja D; Liangpunsakul S; Meng F; Francis H; Alpini G; Huang Q; Glaser S
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1525-1539. PubMed ID: 30890428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
    Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
    Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol suppresses cholestasis-induced liver injury and fibrosis in rats associated with the inhibition of TGFβ1-Smad3-miR21 axis and profibrogenic and hepatic injury biomarkers.
    ShamsEldeen AM; Al-Ani B; Ebrahim HA; Rashed L; Badr AM; Attia A; Farag AM; Kamar SS; Haidara MA; Al Humayed S; Ali Eshra M
    Clin Exp Pharmacol Physiol; 2021 Oct; 48(10):1402-1411. PubMed ID: 34157155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Expression of S100B and RAGE in a Mouse Model of Bile Duct Ligation-induced Liver Fibrosis.
    Park JW; Kim MJ; Kim SE; Kim HJ; Jeon YC; Shin HY; Park SJ; Jang MK; Kim DJ; Park CK; Choi EK
    J Korean Med Sci; 2021 Apr; 36(14):e90. PubMed ID: 33847081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease.
    Povero D; Eguchi A; Li H; Johnson CD; Papouchado BG; Wree A; Messer K; Feldstein AE
    PLoS One; 2014; 9(12):e113651. PubMed ID: 25470250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.
    Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L
    Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.
    Osawa Y; Hoshi M; Yasuda I; Saibara T; Moriwaki H; Kozawa O
    PLoS One; 2013; 8(6):e65251. PubMed ID: 23755201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
    Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.
    Uchinami H; Seki E; Brenner DA; D'Armiento J
    Hepatology; 2006 Aug; 44(2):420-9. PubMed ID: 16871591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1/SHP/EID1 network.
    Zhang Y; Xu N; Xu J; Kong B; Copple B; Guo GL; Wang L
    Hepatology; 2014 Sep; 60(3):919-30. PubMed ID: 24619556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice.
    Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Ommati MM; Abdoli N; Aghaei F; Esfandiari A; Azarpira N; Niknahad H
    Biomed Pharmacother; 2018 Jan; 97():1086-1095. PubMed ID: 29136945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.